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[Abstract] Developing protocols to obtain intestinal epithelial monolayers that recapitulate in vivo 
physiology to overcome the limitations of the organoids’ closed geometry has become of great interest 
during the last few years. Most of the developed culture models showed physiological-relevant cell 
composition but did not prove self-renewing capacities. Here, we show a simple method to obtain mouse 
small intestine-derived epithelial monolayers organized into proliferative crypt-like domains, containing 
stem cells, and differentiated villus-like regions, closely resembling the in vivo cell composition and 
distribution. In addition, we adapted our model to a tissue culture format compatible with functional 
studies and prove close to physiological barrier properties of our in vitro epithelial monolayers. Thus, we 
have set-up a protocol to generate physiologically relevant intestinal epithelial monolayers to be 
employed in assays where independent access to both luminal and basolateral compartments is 
needed, such as drug absorption, intracellular trafficking and microbiome-epithelium interaction assays. 
Keywords: Mouse intestinal organoids, Adult intestinal stem cells, Matrigel, Intestinal epithelial 
monolayer, In vitro intestinal epithelial model, Tissue-like functionality, TEER 
 
[Background] The development of epithelial organoid culture systems is a major scientific achievement 
that has been established as an important tool in many basic biology and clinical applications due to 
their similarity in cell composition and function to the in vivo organ. Specifically, intestinal epithelial 
organoids are spherical formations with budding structures containing stem, Paneth and proliferative 
cells, corresponding to intestinal crypts, and inter-budding areas of differentiated cells representing the 
intestinal villi (Sato et al., 2009; Ootani et al., 2009). One of the major drawbacks of the intestinal 
organoid system is their closed-spherical structure which hampers their use in standard functional 
assays in which direct access to the organoid lumen or apical site of the epithelium is required. In the 
last few years, several attempts to open-up the spherical organoids into 2D monolayers have been 
established (Moon et al., 2014; VanDussen et al., 2015; Ettayebi et al., 2016; In et al., 2016; Kozuka  
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et al., 2017). However, the reported epithelial monolayers were mainly composed of mature epithelial 
cells with poor characterization of the proliferation and self-renewing capacities. More recently, methods 
to obtain monolayers with both proliferative and differentiated regions have been published. Although 
showing a physiologically relevant cell composition and distribution, those monolayers did not expand 
enough to cover the full substrate area and did not allow access to the basolateral site preventing their 
use in functional assays (Wang et al., 2017a; Liu et al., 2018; Thorne et al., 2018). 
  Here, we describe an experimental protocol in which we grow either Lgr5-EGFP-ires-Cre ERT2 
mouse organoid-derived crypts or single cells on a thin layer of Matrigel to obtain intestinal epithelial 
monolayers that self-organize in crypt foci, containing stem cells, Paneth and proliferative cells, and villi-
like regions composed of differentiated cells, resembling the cell distribution found in the in vivo small 
intestine. Importantly, our results indicate that the capacity of the intestinal epithelial cells to first self-
organize into crypt-like domains and then originate villus-like regions is regulated intrinsically and is not 
due to the preservation of pre-established crypt configuration. We successfully adapted this method to 
a Transwell inserts culture format, as previously described (Wang et al., 2017b), which allow an 
independent access to the basolateral and apical compartments, and demonstrate that the basolateral 
administration of crypt medium supplemented with non-epithelial niche-derived biochemical factors 
boosted epithelial monolayer expansion to fully cover the tissue culture substrate without altering the 
crypt-villus-like cell distribution. 
  These features of our model enable to perform functional assays such as to record transepithelial 
electrical resistance (TEER) measurements to determine the monolayers’ epithelial barrier properties. 
We found that TEER values were within the expected physiological range (40-100 Ω cm2) for mouse 
small intestine, demonstrating an adequate maturation of de novo generated epithelium. Overall, we 
have developed a protocol to generate organoid-derived intestinal epithelial monolayers with in vivo-like 
structural and functional features in a culture format compatible with functional assays. We believe our 
technology meet the necessary features of the complex 3D organotypic cell culture systems and 2D 
formats for a close to physiological high-throughput testing. 
 
Materials and Reagents 
 
A. Materials 
1. Petri dishes, 94 x 16 mm, sterile (Biolab, catalog number: 020005) 
2. Glass coverslips 24 x 24 mm (Deltalab, catalog number: D102424) 
3. Serological pipettes 5 ml, 10 ml, 25 ml (Nunc, catalog numbers: 056815, 056816, 056817) 
4. Racked filter pipette tips 20 µl, 200 µl, 1,000 µl, sterile (Labclinics, catalog numbers: 
LAB20ULFNL, LAB200ULFNL, LAB1000ULFNL) 
5. 70 µm pore cell strainer (Biologix Research Co., catalog number: 151070) 
6. 24-well multiwell plates (Nunc, catalog number: 142485) 
7. Falcon, 50 ml centrifuge tubes (Deltalab, Eurotubo, catalog number: DEL429927) 
8. Falcon, 15 ml centrifuge tubes (Deltalab, Eurotubo, catalog number: DEL429946) 
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9. Ibidi 8-well µ-Slides (Ibidi GmbH, catalog number: 80826) 
10. Transwell polycarbonate membrane cell culture inserts, 6.5 mm diameter, 0.4 µm pore size 
(Corning, catalog number: CLS3413) 
11. 23 G 1" needle (BD Microlance 3, catalog number: 300800) 
12. Disposable 1 ml syringe (B-Braun, catalog number: 9166017V) 
13. Disposable 10 ml syringe (Becton Dickonson, catalog number: 309110) 
14. Cell culture flasks, filter cap 25 cm2 (Nunc EasYFlasks, catalog number: 156367) 
15. Syringe filter, 0.22 µm pore size, sterile (Millipore, Millex, catalog number: SLGP033RS) 
 
B. Reagents 
1. Phosphate buffered saline (PBS) powder, pH 7.4 (Sigma-Aldrich, catalog number: P3813), store 
at RT 
2. Ethylenediaminetetraacetic acid (EDTA) solution, pH 8.0, ~0.5 M (Sigma-Aldrich, catalog 
number: 03690), store at RT 
3. Matrigel Basement membrane matrix, LDEV-free (Corning, catalog number: 354234), store at  
-20 °C 
Note: Thaw O/N on ice and aliquot in 0.5-1 ml vials upon arrival, to minimize freeze and thaw 
cycles. 
4. Advance Dulbecco’s modified medium (DMEM)/F12 (Thermo Fisher Scientific, Gibco, catalog 
number: 12634010), store at 2-8 °C 
5. GlutaMAX supplement, 100x (Thermo Fisher Scientific, Gibco, catalog number: 35050038), 
store at 2-8 °C 
6. 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer solution, 1 M (Thermo 
Fisher Scientific, Gibco, catalog number: 15630056), store at 2-8 °C 
7. Normocin (InvivoGen, catalog number: ant-nr-2), store at -20 °C 
8. B-27 supplement, minus vitamin A, 50x (Thermo Fisher Scientific, Gibco, catalog number: 
12587010), store at -20 °C aliquoted 
9. N-2 supplement, 100x (Thermo Fisher Scientific, Gibco, catalog number: 17502048), store at  
-20 °C aliquoted 
10. N-Acetyl-L-cysteine (Sigma-Aldrich, catalog number: A9165), store at -20 °C aliquoted 
11. Recombinant murine Epidermal growth factor (EGF) (Thermo Fisher Scientific, Gibco, catalog 
number: PMG8043), store at -20 °C aliquoted 
12. Recombinant human R-spondin 1 (R&D Systems, catalog number: 4645-RS-250), store at     
-20 °C aliquoted 
13. Recombinant murine Noggin (Peprotech, catalog number: 250-38), store at -20 °C aliquoted 
14. Y-27632 Dichloride, powder (Sigma-Aldrich, catalog number: Y0503, reconstitute at 1 mM in 
sterile Milli-Q and store at -20 °C aliquoted) 
15. CHIR99021 (Stemgent, catalog number: 04-0004), store at -20 °C aliquoted 
16. Valproic acid sodium salt (Sigma-Aldrich, catalog number: P4543, reconstitute at 1 M in sterile 
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Milli-Q and store at -20 aliquoted) 
17. TrypLE Express enzyme, with phenol red, 1x (Thermo Fisher Scientific, Gibco, catalog number: 
12605010), store at 2-8 °C 
18. Fetal bovine serum (FBS), heat inactivated (Thermo Fisher Scientific, Gibco, catalog number: 
10500064), store at -20 °C 
19. DMEM, high glucose, GlutaMAX supplement, pyruvate (Thermo Fisher Scientific, Gibco, 
catalog number: 31966021), store at 2-8 °C 
20. Penicillin-streptomycin, with 10,000 units penicillin and 10 mg streptomycin per ml in 0.9% NaCl 
(Sigma-Aldrich, catalog number: P0781), store at -20 °C 
21. Minimum essential medium non-essential amino acid (MEM-NEA) solution, 100x (Thermo 
Fisher Scientific, Gibco, catalog number: 11140035), store at 2-8 °C 
22. Collagenase (Sigma-Aldrich, catalog number: C0130), store at -20 °C 
23. ACK Lysing Buffer (Gibco, catalog number: A10492-01), store at RT 
24. Ethanol, 96% v/v (PanReac Applichem, catalog number: 131085), store at RT 
25. Intestinal organoid growth medium or ENR_CV medium (see Recipes section, Table 1) 
26. Intestinal subepithelial myofibroblast digestion medium (see Recipes section, Table 2) 
27. Intestinal subepithelial myofibroblast culture medium (see Recipes section, Table 3) 
28. Boosting medium (see Recipes section, Table 4) 
29. Basic-medium (see Recipes section, Table 5) 




1. Surgical tweezers (Biolab, catalog numbers: 711198 and 711199) 
2. Surgical scalpel (Paramount, catalog number: PCS23) 
3. Surgical scissors (Biolab, catalog number: 005064) 
4. 37 °C water bath (Fisher Scientific, Polytest 20) 
5. Milli-Q water purification system (Millipore, Q-POD) 
6. Neubauer counting chamber (BRAND, catalog number: 718605) 
7. Micropipettes (Gilson, models: P20, P200, P1000) 
8. Pipette aid (Eppendorf, Easypet) 
9. Cell culture benchtop centrifuge (Beckman Coulter, model: Allegra X-12R) 
10. 37 °C humidified incubator with 5% CO2 (Thermo Scientific, Steri-Cult 3141) 
11. Laminar flow hood (Telstar, BIO II A) 
12. Platform Shaker (Heidolph, model: Unimax 1010) 
13. Incubated benchtop orbital shaker (Thermo Scientific, 4518 S/N 15150-131) 
14. Bright field microscope (Nikon, Eclipse Ts2) 
15. Epithelial voltohmmeter with STX3 electrodes (World Precision Instruments, EVOM2) 
16. Ice machine (Scotsman, MF56) 
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A. Intestinal crypt isolation and culture (Figure 1A) 
Note: Perform until Step A8 on the bench and from then onwards you might continue the protocol 
under a laminar flow hood to favor sterility. 
 
 
Figure 1. Overview of the developed methodology for the generation of in vitro intestinal 
epithelial monolayer. A. Intestinal crypts are isolated from Lgr5-EGFP-IRES-creERT2 mouse 
and grown in Matrigel drops to obtain the organoid culture. Organoids are dissociated into B. 
crypt pieces or C. single cells and seeded on Matrigel coated standard tissue culture plates or 
Transwell inserts to obtain a 2D in vitro intestinal epithelial culture system. 
 
1. Harvest the small intestine from Lgr5-EGFP-IRES-creERT2 mouse. 
2. Place the intestine into a Petri dish with PBS and remove the fat and mesentery from the tissue 
using surgical tweezers and a scalpel or surgical scissors. 
Note: Be careful not to rupture the intestinal tissue. 
3. Flush the mouse small intestine with PBS using a 10 ml syringe and a 23 G 1" needle. 
4. Cut up the tissue longitudinally using surgical scissors. 
Note: Make sure that when you cut open the tissue the mucosal side is facing upwards. 
5. Remove the villi mechanically by scraping carefully the intestinal mucosa with a glass coverslip. 
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Note: Be careful not to apply too much pressure to preserve the crypts. 
6. Rinse 3 times with PBS and place the intestine into a new Petri dish. 
7. Cut the tissue into pieces of 1-4 mm thick using surgical scissors (see Figure 2). 
 
 
Figure 2. Picture showing the appearance (size and shape) of the tissue pieces obtained 
after cutting the intestine using surgical scissors. 
 
8. Transfer the pieces into a sterile 50 ml Falcon tube under the laminar flow hood. 
9. Add 10 ml ice-cold PBS and pipette up and down 5-6 times using a 10 ml pipette. Let the pieces 
settle and discard the supernatant. 
Note: It is very important that the PBS is ice cold and that the inner pipettes walls are previously 
wetted with PBS. If not, the tissue pieces might stick to the pipette. 
10. Add fresh 10 ml ice-cold PBS and repeat the Step A9 for 10-20 times until the supernatant 
becomes almost clear. 
Note: The supernatant might still be a bit cloudy after 20 washes, proceed with the next step 
anyways. 
11. Add 25 ml of 2 mM EDTA prepared in cold PBS and incubate it for 30 min at 4 °C. Agitate 
vigorously the Falcon tube during incubation on a platform shaker. 
12. After the incubation, let the tissue pieces settle to the bottom of the Falcon tube and discard the 
supernatant. 
13. Add 10 ml of ice-cold PBS with 10% FBS to the tissue pieces using 10 ml pipette. It is 
recommended to wet the inner wall of the pipette with ice cold-PBS with 10% FBS to avoid 
tissue pieces sticking to the pipette. 
14. Pipette up and down 3-5 times the tissue pieces using a 10 ml pipette. Let the pieces to settle 
down and filter the supernatant through a 70 µm pore cell strainer placed on top of a new 50 ml 
Falcon tube. The eluted solution will correspond to the first crypt elution fraction. 
15. Repeat the Steps A13 and A14 for 4-5 times more to obtain the following crypt elution fractions. 
Use new 70 µm pore cell strainers and new 50 ml Falcon tubes to collect the subsequent crypt 
elution fractions. 
16. Pipette 5 µl of each of the eluted fractions in a Petri dish and analyze them using a bright field 
microscope, to determine the purity and the size of the crypts in each fraction. 
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Note: Usually, the first fractions contain a lot of debris and some villi pieces. It is advisable to 
discard these fractions and keep the rest, which mainly contain small crypt pieces (Figure 3). 
17. Pool the selected fractions in a 50 ml Falcon tube and centrifuge the suspension at 55 x g for  
5 min at 8 °C. 
Note: In the case reported in Figure 3, we would discard fraction 1 and pool fractions 2, 3 and 
4. 
18. Resuspend the pellet containing the crypts in pre-thawed Matrigel by gently pipetting 2-3 times 
using a P1000 micropipette and cold 1,000 µl pipette tips. The resuspension volume will depend 
on the number of eluted fractions pooled and therefore the size of the obtained pellet. For 
example, in the case reported in Figure 3, in which we have polled fractions 2, 3 and 4 (Figure 
3A) and obtained the pellet of cells shown in Figure 3B we would use 500 µl of Matrigel to 
resuspend the pellet. 
Note: Thaw an aliquot (1 ml) of Matrigel on ice at least 1 h before using it. At this step of the 
protocol you must work always on ice to prevent Matrigel from solidifying. 
19. Pipette carefully a bubble-free 40 µl drop of crypt-Matrigel suspension per well in a pre-warmed 
24-well plate. Usually you will obtain around 15 drops. Place the plate into a 37 °C incubator for 
5-10 min to let the Matrigel solidify. 
Note: Place the 24-well plate into the incubator at 37 °C for 10 min prior to seeding. This helps 
the drops to form properly. 
 
 
Figure 3. Elution process of the different crypt fractions. A. Bright field microscopy pictures 
showing 4 different crypt elution fractions of a given intestinal crypt isolation. Scale bar: 100 µm. 
B. Image showing the pellet of cells obtained from pooling crypt eluted fractions 2 + 3 + 4 of the 
isolation shown in Figure 3A. 
 
20. Add 400 µl of the pre-warmed intestinal organoid growth medium (Table 1) into each well after 
Matrigel solidifies and transfer them back to the 37 °C humidified incubator with 5% CO2. 
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21. Add extra ENR-CV factors (same concentration as in Table 1) every other day, in the current 
culture medium, during the first 4-5 days of the culture and Rho kinase inhibitor (Y-27632) (10 
µM) every day for the first 4 days to avoid epithelial cells death by anoikis. Change the whole 
medium every 2-3 days. Alternatively, add 100 µl fresh medium every other day until passing of 
the organoids. 
Note: Typically, crypts will start budding after 2-3 days in culture (Figure 4). Passage outgrow 
crypts after one week in culture. In case crypt confluence is very high, an earlier passage of the 
budding crypts will be required for a proper organoid formation. Typically, in the original drops 
we obtain around 100-125 organoids per drop. 
 
 
Figure 4. Bright field microscopy images showing the growth and budding of freshly 
isolated intestinal crypt over time (up to 3 days). Notice that intestinal crypts start to bud 2-
3 days in culture after isolation. Scale bar: 100 µm. 
 
B. Passaging crypts after organoid formation 
1. Thaw Matrigel at least 1 h before the experiment by leaving the aliquots on ice. 
2. Prepare and pre-warm the organoid growth medium (Table 1) and 24-well plates at 37 °C. 
3. Remove the organoid growth media from the wells containing full-grown organoids (see Figure 
5, left panels) add 300 µl TrypLE Express 1x to each well and gently detach and disrupt the 
Matrigel drops by scraping it off using a P1000 micropipette. This step is performed at RT. 
Notes: 
a. You can use 300 µl TrypLE Express 1x volume to recover organoids from 2 drops. 
b. TrypLE Express 1x is used in this step to obtain crypts with more homogeneous size and 
favor Matrigel digestion. 
4. Transfer the Matrigel suspension to a 15 ml Falcon tube already placed on ice. 
5. Pass the suspension through a 1 ml syringe with a 23 G 1" needle 3-4 times to further 
mechanically disrupt the organoids. This step is performed on ice. 
Note: The number of times you pass the sample through the syringe and the force you apply 
will depend on the size of the full-grown organoids you intend to break. Be aware that a too 
gentle procedure would not break the organoids and too harsh will over-digest the crypts. 
6. Add 1 ml of 2% FBS in PBS for every 300 µl of suspension and agitate manually the tube to mix 
well the content. 
Note: This step might be repeated in case a further wash is required. 
7. Centrifuge at 72 x g for 3 min at 8 °C. 
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8. Remove all the supernatant and resuspend the pellet in fresh Matrigel by gently pipetting using 
a micropipette. Resuspension volume will depend on the number of initial drops digested. 
Note: Splitting ratio is usually 1:4-1:5. 
9. Plate the Matrigel containing crypts drops (40 µl/drop) in pre-warmed 24-well plates as 
explained before. 
10. Polymerize the Matrigel by incubating at 37 °C for 5-10 min. 
11. Add 400 µl of the intestinal organoid growth medium (Table 1) to each well and transfer the 
plate back to a 37 °C humidified incubator with 5% CO2. 
Note: See Figure 5 (middle panels) for a representative bright field microscope image of freshly 
dissociated intestinal organoid-derived crypts. 
 
 
Figure 5. Representative bright field microscope images of full-grown intestinal 
organoids (left panels), freshly dissociated intestinal organoids-derived crypts (middle 
panels) and freshly digested intestinal organoids-derived single cells (right panels), 
grown in Matrigel drops. Insets show a magnification of the corresponding images. Please 
notice that due to the 3D culture not all cellular structures are in the same focus. Scale bars: 
100 µm, 50 µm (inset). 
 
C. Preparation of Matrigel-coated substrates 
1. Place the ibidi 8-well µ-Slides or Transwell inserts and P20 micropipette tips into the freezer 
beforehand. 
Note: This step is especially important for obtaining homogeneous Matrigel coating. 
2. Thaw Matrigel at least 1 h before the experiment by leaving the aliquots on ice. 
3. Place the pre-cooled ibidi plate on ice. Pipette 10 µl of Matrigel using a P20 micropipette and 
pre-cooled micropipettes in each of the ibidi plate wells or in each of the Transwell insert. Make 
sure that the 10 µl of Matrigel are uniformly spread throughout the substrate surface by moving 
the pipette tip while releasing the Matrigel (see Video 1). 
Note: Remove the excess Matrigel that accumulates at the Transwell insert border. 
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Video 1. Preparation of Matrigel-coated substrates 
 
4. Repeat the Step C3 for all the wells and inserts required. 
Note: Perform Steps C3 and C4 as fast as possible for a homogeneous coating. 
5. Incubate the plates or inserts at 37 °C for 1h in the incubator to polymerize the Matrigel. 
6. Continue with the seeding (see following Procedure D). 
 
D. Generation of organoid-derived intestinal epithelial monolayers 
1. Intestinal organoid-derived crypt seeding (Figure 1B) 
a. Digest organoids to obtain crypts with homogeneous sizes as described in Steps B1-B6. 
Note: See Figure 5 (middle panels) for a representative bright field microscope image of 
freshly dissociated intestinal organoid-derived crypts. 
b. Mix well the Falcon containing the digested organoid suspension, take 3 times 5 µl samples 
using a P20 micropipette and place them into a Petri dish. 
c. Count and average the number of crypt pieces within the 5 µl volume using a bright field 
microscope and from that value estimate the total number of crypt pieces in the suspension. 
d. Centrifuge to collect the crypt pieces at 72 x g for 3 min at 4 °C. 
e. Resuspend the pellet in intestinal organoid growth medium (Recipe 1). Calculate the total 
medium volume needed for a seeding density of 1,500 crypts/cm2. 
Notes: 
i. The surface area of one well of ibidi 8-well µ-Slides is 1 cm2. Then, the seeding density 
is 1,500 crypts/sample. 
ii. For reference purposes, from one full-grown organoids Matrigel drop (Figure 5, left 
panels) we obtained approximately 1,000-1,500 crypts. 
f. Pipette 30-50 µl of crypt suspension into each well of the Matrigel-coated ibidi 8-well µ-
Slides (see Procedure C). Try to place the sample as a drop in the center of the well. 
g. Let the crypts attach to the substrate for 3-4 h and add 200 µl more of intestinal organoid 
medium (Table 1). 
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h. Change the medium every other day. 
i. Inspect the monolayer formation and growth throughout the culture time using a bright field 
microscope. After seeding, organoid-derived crypts will rapidly refold on themselves to form 
crypt-like domains containing Lgr5+ intestinal stem cells (GFP+). Then, cells spread on the 
substrate and migrate out of the crypt-like domains, forming epithelial monolayers 
composed on GFP- cells which correspond to the villus-like regions (Figure 6A). 
2. Intestinal organoid-derived single cell seeding (Figure 1C) 
a. Follow the organoids digestion protocol as described in Steps B1-B4. 
b. Pass the suspension through 1 ml syringe with a 23 G 1” needle 5-6 times followed by a   
5 min incubation at 37 °C. Agitate the cell suspension every minute to disrupt well the cell 
aggregates. After 5 min of incubation, place the sample on ice, pipette 5 µl of the digestion 
on a Petri dish and inspect the sample under the microscope. If cell aggregates are still 
observed increase the incubation time (37 °C) for some more min (up to a total of 8 min). 
Note: See Figure 5 (right panels) for a representative bright field microscope image of 
freshly digested intestinal organoid-derived single cells. 
c. Once single cell suspension is achieved, place the tube on ice and add 1 ml of PBS with 
2% FBS for every 300 µl of suspension and agitate manually the tube to mix well the content. 
Note: This step might be repeated in case a further wash is required. 
d. Count the number of cells in the suspension using a Neubauer counting chamber. 
e. Centrifuge at 110 x g for 4 min at 4 °C. 
f. Resuspend the pellet in organoid growth medium (Table 1). Calculate the total medium 
volume needed for a seeding density of 105 cells/cm2. 
Notes: 
i. The surface area of one well of ibidi 8-well µ-Slides is 1 cm2. Then, the seeding density 
is 105 cells/sample. 
ii. For reference purposes, from one full-grown organoids Matrigel drop (Figure 5, left 
panels) we obtained approximately 1.5 x 105-1.7 x 105 single cells. 
g. Seed the Matrigel-coated ibidi 8-well µ-Slides (see Procedure C) with 10-20 µl of single cell 
suspension. 
Note: Place the single cell suspension drop into the center of the well and be careful to not 
to disrupt it. 
h. Let the cells attach for 1 h, add 200 µl more of intestinal organoid medium (Table 1) plus 
Rho kinase inhibitor Y-27632 at 10 µM final concentration. 
i. Change the medium every other day. 
j. Inspect the monolayer formation and growth using a bright field microscope. After seeding, 
organoid-spontaneously self-assemble to form crypt-like domains containing Lgr5+ ISCs, 
closely mimicking the in vivo arrangement at the crypt bases. Then, cells start to spread out 
generating epithelial monolayers composed of GFP- giving rise to the villus-like regions 
(Figure 6B). 
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Figure 6. Stem cells self-assemble in crypt-like domains and originate epithelial 
monolayers. (A) Live-imaging sequence of overlapped bright field and GFP signal 
corresponding to 60 hours after seeding organoid-derived crypts and (B) 96 hours after 
seeding organoid-derived single cells on a thin film of Matrigel. The corresponding time for 
each snapshot is shown in each panel. White arrow heads indicate Lgr5-GFP+ cells. Scale 
bars: 50 µm (A, upper row) and 100 µm (A, lower row, and B). Figure adapted from the 
original publication (Altay et al., 2019, under Creative Commons Attribution 4.0 International 
License, http://creativecommons.org/licenses/by/4.0/). 
 
E. Intestinal subepithelial myofibroblast isolation and culture 
1. Collect the tissue left from the crypt digestion and elution described in Step A15. 
2. Add 10 ml of 3 mM EDTA in PBS and incubate for 10 min at 37 °C and 200 rpm in an incubated 
benchtop orbital shaker. 
Note: Pre-warm the EDTA solution to 37 °C. 
3. After incubation, let the pieces settle down and discard the supernatant. Repeat Step E2 two 
more times. 
4. Discard the supernatant and rinse the pellet with 20 ml of PBS. Repeat this step 2 times more. 
Note: This step is important to remove all EDTA. 
5. Discard the supernatant and add intestinal epithelial myofibroblast digestion medium (Table 2). 
6. Incubate for 40 min in an incubated benchtop orbital shaker at 37 °C and 200 rpm. 
7. After the incubation, pipette the suspension up and down during 1 min using 10 ml pipette. 
8. Centrifuge at 160 x g for 5 min. 
9. Resuspend the pellet with 10 ml of ACK lysing Buffer (pre-warmed at 47 °C). 
10. Centrifuge at 160 x g for 5 min. 
11. Resuspend the pellet with 10 ml intestinal epithelial myofibroblast culture medium (Table 3) and 
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culture in 25 cm2 cell culture flask. 
Note: Tissue pieces will eventually attach to the flask and myofibroblasts will grow out and 
spread though the flask. Replace the medium every 3-4 days. Usually, 2-3 weeks after isolation 
flask will be confluent. Figure 7 shows representative bright field microscopy images of this 
process. 
12. Cell are passaged by normal trypsinization for 5 min. Splitting ration 1:3. 
 
 
Figure 7. Representative bright field microscopy images of ISEMF growth on tissue 
culture flasks at day 9 (left panel) and day 19 (right panel) after seeding. Notice that 
digested tissue pieces attach to the plastic and emerging fibroblast spread through the flask 
until reaching confluence. This process might take 21 days. Scale bar: 200 µm. 
 
F. Intestinal subepithelial myofibroblast conditioned medium (ISEMF_CM) production 
1. Grow 60-80% confluent ISEMF cultures for 4-6 days without changing the medium (Figure 8). 
2. Harvest the medium and centrifuge it at 160 x g for 5 min to remove debris. 
Note: Add fresh intestinal epithelial myofibroblast culture medium (Table 3) to the plates and 
continue the culture. Passage the cells if required (Step E12). 
3. Collect the supernatant and filter it using a 0.22 µm pore size filter and a 10 ml syringe. 
4. Store the filtered ISEMF_CM at -80 °C until use. 
5. Repeat Steps F1-F4 until cells become senescent (usually after 5-6 passages). 
6. Pool all ISEMF_CM fraction collected from the same ISEMF isolation and prepare the boosting 
medium as described in Table 4. 
 
 
Figure 8. Bright field microscopy images showing the growth of ISEMF during 6 days 
after splitting. ISEMF_CM is collected during this period when ISEMF confluence is around 60 
to 80%. 
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G. Evaluating the epithelial monolayer formation and barrier integrity with transepithelial electrical 
resistance (TEER) measurements 
1. Prepare Matrigel-coated Transwell inserts as explained in Procedure C. 
2. Follow the steps described in Step D1a until Step D1d to dissociate the organoids to crypts. 
3. Resuspend the pellet in basic-medium (Table 5). Calculate the total medium volume needed for 
a seeding density of 3,000-3,500 crypts/cm2. 
Notes:  
a. The surface area of one 6.5 mm diameter Transwell insert is 0.33 cm2. 
b. For reference purposes, from one full-grown organoids Matrigel drop (Figure 5, left panels) 
we obtained approximately 1,000-1,500 crypts. 
4. Seed each of the Matrigel-coated Transwell inserts with 30-50 µl of crypt suspension. 
Note: Leave 2-3 Matrigel-coated Transwell inserts without seeding as controls for TEER 
measurements. 
5. Let the crypts attach for 1-2 h and add 200 µl more of basic-medium (Table 5) at the apical 
(upper) side of the Transwell. 
6. Prepare the boosting medium (Table 4) and add 500 µl to the basolateral (bottom) side of the 
Transwell. 
7. Add the corresponding medium to the control (no cells) inserts as well. 
8. Place the plate in a 37 °C humidified incubator with 5% CO2. Change the medium of both apical 
and basolateral sides every other day. 
9. After changing medium, let the plate under the hood at RT for 5-10 min so that the medium 
temperature equilibrates. 
10. In the meanwhile, sterilize the EVOM2 epithelial voltohmmeter STX3 electrodes by submerging 
them into 70% Ethanol (Table 6) for 15 min. 
11. Rinse the electrodes with PBS and keep them in the solution until starting the measurements. 
12. Turn on the voltohmmeter, plug the electrodes and introduce one to the apical and the other to 
the basolateral side of the Transwell. Record the value measured. 
13. Remove the electrodes and reinsert to measure again. Repeat this step one more time to obtain 
3 different measurements from the same sample. 
14. Wash the electrodes in between measurements by submerging into PBS and then into basic 
medium. 
15. After finishing the measurements, sterilize the electrodes by submerging them into 70% Ethanol 
for 15 min. Rinse them with sterile Milli-Q, let them air-dry under the cell culture hood and store. 
16. Measure the TEER of the monolayers every 2 days, up to 20 days of culture. 
17. Calculate the electrical resistance corresponding to epithelial monolayers by subtracting the 
intrinsic resistance (values measured on control samples without cells) from the total resistance 
measured (samples with the cells) and corrected for surface area (0.33 cm2) expressed as 
ohm·cm2. 
                 
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.  15 
www.bio-protocol.org/e3514     




Note: For reference purposes, TEER values progressively increase up to approximately 60 




For statistical comparison, we used two-tailed, unequal variance t-test and we considered P < 0.05 
to be significant. We repeated monolayer formation protocol in at least three independent 
experiments. We performed three independent experiments with two technical replicas per condition 
per experiment for TEER measurements. The detailed explanation of data analysis performed, can 
be found in the Materials and Methods, and Supplementary Information sections of the original 
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1. Intestinal organoid growth medium or ENR_CV medium 
 
Table 1. Component list for the formulation of the intestinal organoid growth medium or 
ENR_CV medium. Stock and final concentration are indicated, as well as the solvent employed 
(when required). Volumes for each of the components (at stock concentration) for a final volume 









Glutamax 100x  200 µl 1% v/v 
HEPES 1 M  200 µl 1% v/v (10 mM) 
Normocin 50 mg/ml  40 µl 100 µg/ml 
B-27 50x  400 µl 2% v/v 
N-2 100x  200 µl 1% v/v 
N-Acetyl-L-
cysteine 
500 mM Milli-Q 50 µl 1.25 mM 
Advanced 
DMEM/F12 
  18,910 µl  
EGF 100 µg/ml PBS 20 µl 100 ng/ml 
Noggin 100 µg/ml PBS 20 µl 100 ng/ml 
R-Spondin 1 100 µg/ml PBS 40 µl 200 ng/ml 
CHIR99021 10 mM DMSO 6 µl 3 µM 
Valproic acid 1 M Milli-Q 20 µl 1 mM 
If not prepared fresh, this medium (without adding the ENR_CV) can be stored at 2-8 °C up to 
2 weeks. ENR_CV must be added just before use. 
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Table 2. Component list for the formulation of the intestinal subepithelial myofibroblast 
digestion medium. Stock and final concentration are indicated, as well as the solvent employed 
(when required). Volumes for each of the components (at stock concentration) for a final volume 









FBS   4,000 µl 20% v/v 
Collagenase 100 mg/ml PBS 75 µl 0.37 mg/ml (100 
U/ml) 
DMEM   16,000 µl  
Add the enzyme just before using the medium. 
 
3. Intestinal subepithelial myofibroblast culture medium 
 
Table 3. Component list for the formulation of the intestinal subepithelial myofibroblast 
culture medium. Stock and final concentration are indicated, as well as the solvent employed 
(when required). Volumes for each of the components (at stock concentration) for a final volume 
of 20 ml of medium are shown. 
Reagent Stock 
concentration 
For 20 ml final volume (store 
at 2-8 °C up to 2 weeks) 
Final concentration  
FBS  2,000 µl 10% v/v 
Penicillin-
streptomycin 
100x 200 µl 1% v/v 
MEM-NEA 100x 200 µl 1% v/v 
Normocin 50 mg/ml 40 µl 100 µg/ml 
DMEM  17,560 µl  
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4. Boosting medium 
 
Table 4. Components list for the formulation of the boosting medium. Stock and final 
concentration are indicated, as well as the solvent employed (when required). Volumes for each 









Glutamax 100x  200 µl 1% v/v 
HEPES 1 M  200 µl 1% v/v (10 mM) 
Normocin 50 mg/ml  40 µl 100 µg/ml 
B-27 50x  400 µl 2% v/v 
N-2 100x  200 µl 1% v/v 
N-Acetyl-L-
cysteine 
500 mM Milli-Q 50 µl 1.25 mM 
ISEMF_CM   18,910 µl  
EGF 100 µg/ml PBS 20 µl 100 ng/ml 
Noggin 100 µg/ml PBS 20 µl 100 ng/ml 
R-Spondin 1 100 µg/ml PBS 40 µl 200 ng/ml 
CHIR99021 10 mM DMSO 6 µl 3 µM 
Valproic acid 1 M Milli-Q 20 µl 1 mM 
Wnt3a 100 µg/ml Milli-Q 5 µl 25 ng/ml 
If not prepared fresh, this medium (without adding the ENR_CV and Wnt3a factor) can be stored 
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Table 5. Components list for the formulation of the basic-medium. Stock and final 
concentration are indicated, as well as the solvent employed (when required). Volumes for each 





For 20 ml final volume (store 
at 2-8 °C up to 2 weeks) 
Final 
concentration 
Glutamax 100x  200 µl 1% v/v 
HEPES 1 M  200 µl 1% v/v (10 mM) 
Normocin 50 mg/ml  40 µl 100 µg/ml 
B-27 50x  400 µl 2% v/v 
N-2 100x  200 µl 1% v/v 
N-Acetyl-L-
cysteine 
500 mM Milli-Q 50 µl 1.25 mM 
Advanced 
DMEM/F12 
  18,910 µl  
 
6. 70% v/v Ethanol 
 
Table 6. Components list for the preparation of 70% v/v Ethanol. Volumes for each of the 
components (at stock concentration) for a final volume of 1 L are shown. 
Reagent Stock 
concentration 
For 1 L final volume (store at 
RT) 
Final concentration 
Ethanol 96% v/v 230 ml 70% v/v 
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